What’s new

U.S. stock benchmarks opened higher Wednesday, as the market appeared to steady after four straight declines for the Dow. The Dow Jones Industrial Average opened 75 points, or 0.3%, higher at 22,356. If the Dow slips a fifth session in a row, it would mark its longest string since March, according to FactSet data. The S&P 500 index was up about 10 points, or 0.4%, at 2,505, while the Nasdaq Composite Index was 38 points, or 0.6%, higher at 6,419. In individual stocks, shares of Nike were off 4% after the athletic-apparel giant late Tuesday posted disappointing quarterly results. Shares of the Dow component were exacting a roughly 16 point toll on the price-weighted benchmark. Investors are waiting a major Republican announcement on tax reform, which could influence trading.

Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

…read more

From:: Stock Market News

Delta Air Lines Inc. said Wednesday it will begin offering free texting in flight, beginning Oct. 1. The company said it will become the first “global carrier,” which it described as a U.S.-based airline operating trans-oceanic flights, to offer free mobile messaging. Passengers will be able to access free texting through its Wi-Fi portal page. The stock, which was inactive in premarket trade, has tumbled 8.2% over the past three months, while the NYSE Arca Airline Index has shed 6.2% and the Dow Jones Industrial Average has climbed 4.6%.

Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

…read more

From:: Stock Market News

German finance minister Wolfgang Schäuble is set to become to the next president of the German Bundestag, or parliament, in German Chancellor Angela Merkel’s next administration, according to regional reports. Schäuble, who has long been a critic of the European Central Bank’s loose monetary policy, was previously expected to take on a finance-related role in the European Union.

Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

…read more

From:: Stock Market News

La-Z-Boy Inc. said Wednesday that its Chief Financial Officer Louis Riccio Jr. will retire June 2018. Riccio joined La-Z-Boy in early 2000 after the acquisition of LADD Furniture Inc. and was appointed CFO in 2006. La-Z-Boy has launched a national search for a successor that will continue through the transition period. La-Z-Boy share are unchanged in premarket trading and down 15.6% for the year so far. The S&P 500 index is up 11.5% for 2017 so far.

Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

…read more

From:: Stock Market News

Therapix Biosciences Ltd. shares surged 5.8% in premarket trade Wednesday after the company said preclinical trial results looking at the company’s THC drug candidate in mice found that very low doses of THC “could potentially provide a safe and effective treatment for cognitive decline in aging humans,” according to Professor Yosef Sarne of the Sackler Faculty of Medicine at Tel Aviv University, who designed and conducted the study. Company shares closed at $5.49 on Tuesday. Therapix Biosciences’ drug candidate, THX-ULD01, is an ultra-low dose THC drug; very low doses of THC — the hallucinogenic in cannabis — are “devoid of any psychotropic effect,” Sarne said. In the preclinical trial, the positive effect of THC lasted seven weeks, the company said. The company plans to follow the preclinical trial up with human trials. Therapix Biosciences shares have plummeted 18.7% over the last three months, compared with a 3.2% rise in the S&P 500 .

Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

…read more

From:: Stock Market News

A Dallas jury on Tuesday ordered JPMorgan Chase & Co.[s:JPM] to pay more than $4 billion in damages for mismanaging the estate of a former executive for American Airlines [s:AAL]. The bank was hired by the family of Max Hopper in 2010 to administer his estate, which totaled more than $19 million, but had no last will and testament. The jury found that instead the bank committed fraud, breached its fiduciary duty, and broke a fee agreement. It took years to release assets, the jury was told, and in some cases stock options expired. The bank also ignored requests from Hopper’s widow to sell certain stocks, and paid legal fees out of the estate’s proceeds. “The nation’s largest bank horribly mistreated me and this verdict provides protection to others from being mistreated by banks that think they’re too powerful to be held accountable,” Jo Hopper said in a statement. The bank has said it believes the verdict will be overturned. JPMorgan’s stock has gained 8.6% for the year to date, compared to 11.5% for the S&P 500[s:SPX].

Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

…read more

From:: Stock Market News

Wal-Mart Stores Inc. said Wednesday that it is relaunching its Parent’s Choice baby brand. The roll out of items has been ongoing, and will continue through January 2018. Parent’s Choice began 20 years ago with just baby formula and will grow to 275 items. Key to the line will be a premium diaper, available in select stores and on online, and a line of bedding including 53 pieces. The bedding collection will all be priced $40 or less, with many items less than $13. Baby is a category of focus for rival Target Corp. which has launched lines like PillowFort and Cloud Island in recent months. Wal-Mart shares are nearly flat in premarket trading and up almost 15% for the year so far. The S&P 500 index is up 11.5% for 2017 so far and the Dow Jones Industrial Average is up 12.8% for the period.

Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

…read more

From:: Stock Market News

Immune Pharmaceuticals Inc. shares surged 75% in premarket trade Wednesday after the company said early results from a phase 2 clinical trial for moderate-to-severe bullous pemphigoid were positive. Company shares closed at $1.20 on Tuesday. The results, which came from the first six patients enrolled in the clinical trial for Immune Pharmaceuticals’ bertilimumab, found a decline in patients’ total activity score for the condition of 85%. Patients’ improvement was “rapid,” the company said, with the activity score declining on average by 72% by day 42. Bullous pemphigoid is a rare skin condition that consists of large blisters that can be life-threatening, especially for already-sick older individuals, who the condition commonly afflicts, according to the Mayo Clinic. The company said it will continue to enroll patients in the phase 2 trial, with target enrollment of 12 to 15 patients, and has plans for a larger clinical trial. Immune Pharmaceuticals shares have declined 57.5% over the last three months, compared with a 3.2% rise in the S&P 500 .

Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

…read more

From:: Stock Market News

Shares of Nike Inc. sank 3.1% in premarket trade Wednesday, after a downbeat outlook offset a fiscal first-quarter profit beat. The price decline of $1.64 ahead of the open would shave about 11 points off the price of the Dow Jones Industrial Average . Dow futures were up 22 points ahead of the open. Nike’s stock shot up as much as 3.2% in after-hours trade Tuesday, after the athletic apparel and accessories giant beat profit expectations, but the stock turned lower after the conference call with analysts, in which the company cuts its full-year gross margin outlook. Analyst Sam Poser at Susquehanna Financial kept his rating at neutral but cut his stock price target to $47 from $54, citing continued struggles in North America and a lack of forward visibility. Nike’s stock has gained 1.4% over the past three months through Tuesday, while the Dow has climbed 4.6%.

Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

…read more

From:: Stock Market News